Zinc :: Zinc supplementation found to reduce mortality in older children

A clinical trial conducted by researchers at the Johns Hopkins Bloomberg School of Public concluded that daily zinc supplements reduced the risk of death among children aged 12 to 48 months by 18 percent. However, the researchers did not find any significant reduction in mortality among children 1 to 11 months of age.

Malaria :: G6PD deficiency is associated with significant protection against severe, life-threatening malaria

A case-control study in two populations in Mali, West Africa has shown that glucose-6-phosphate dehydrogenase (G6PD) deficiency is associated with significant protection against severe, life-threatening malaria. Researchers from the US National Institute of Allergy and Infectious Diseases and the University of Bamako, Mali, led by Thomas E. Wellems, report the findings this week in the open access journal PLoS Medicine.

Malaria :: Malaria – The right vaccine in the right place?

A new study by Christopher Plowe and colleagues (University of Maryland School of Medicine) on a malaria vaccine used at a testing site in Mali calls into question whether the best vaccine was chosen to be tested at this particular site.

Malaria :: Sanofi fixed dose malaria drug ASAQ for Africa

Sanofi-aventis and the non-profit Drugs for Neglected Diseases initiative (DNDi) announced that ASAQ, the new fixed-dose combination of artesunate (AS) and amodiaquine (AQ), will soon be available throughout sub-Saharan Africa.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack